Monthly Archives: January 2026

PM-International Reports Sale of One Billion FitLine Products Worldwide

Milestone reflects more than three decades of global product distribution and brand development. 
PM-International has announced a major company milestone, confirming that more than one billion FitLine products have been sold worldwide.
Over the past three decades, the FitLine brand has been used by more than 1,000 professional athletes and sports associations globally, including the ATP Tour, the German Ice Hockey Federation, Paris Basketball, and the Korean Wrestling Federation.
Within global direct selling and health and wellness, long-term product volume milestones are viewed as indicators of sustained consumer demand, continued growth, operational scale, and brand longevity across international markets.
The company described the milestone as a historic achievement that “reflects more than 30 years of scientific innovation, premium product quality and the trust and loyalty of millions of distributors and customers across the globe.”

“This number stands for one billion decisions to trust in FitLine, that make a difference for people every day – and 1 billion times the chance to improve life quality,”

said Rolf Sorg, CEO and Founder of PM-International.

“For this, we are incredibly thankful to our customers and partners.”

The post PM-International Reports Sale of One Billion FitLine Products Worldwide appeared first on Direct Selling Facts, Figures and News.

Read more...

LR Health & Beauty SE Reports FY2025 Results, Plans Bond Restructuring

LR Health & Beauty SE: Preliminary Results For Financial Year 2025, Target Equity Contribution, and Targeted Restructuring of the 2024/2028 Bonds. 
Ahlen, Germany – Based on the preliminary financial results for the financial year 2025, the Management Board of LR Health & Beauty SE (the “Company”) now expects an EBITDA* reported of around EUR 16 million for the financial year 2025 (previously expected to be between EUR 17.0 million and EUR 20.0 million). At the same time, the Management Board of the Company expects sales (revenue from goods sold) of around EUR 277 million for the full year 2025 (previously expected to be between EUR 276 million and EUR 281 million).
Also today, EY-Parthenon announced the completion of a draft IDW S 6 restructuring opinion in respect of the Company. Pursuant to the analysis set out in that draft restructuring opinion, the Company will for the financial year 2028 achieve an EBITDA* of EUR 27.3 million and sales of EUR 281.5 million in the sensitivity case, and an EBITDA* of EUR 31.4 million as well as sales of EUR 284.7 million in the management case.

Against this background, the Company decided today to enter into discussions with its shareholder and with the bondholders of the

Read more...